Welcome to our dedicated page for Nano-X Imaging Ltd. news (Ticker: NNOX), a resource for investors and traders seeking the latest updates and insights on Nano-X Imaging Ltd. stock.
NANO-X IMAGING LTD (Nanox) (NASDAQ: NNOX) is a medical imaging technology company that combines imaging hardware, AI-based software, cloud infrastructure, and teleradiology services. The Nanox news feed on this page aggregates company press releases and market updates so readers can follow how Nanox advances its imaging platform, commercial strategy, and capital markets activity over time.
Nanox’s recent news highlights its Nanox.ARC and Nanox.ARC X multi-source digital tomosynthesis systems, including CE Mark certification for Nanox.ARC in Europe and FDA 510(k) clearance for Nanox.ARC X for general use in multiple clinical indications. Articles also cover distribution agreements and collaborations with partners in countries such as France, the Czech Republic, Greece, Romania, Serbia, Montenegro, and Bosnia and Herzegovina, reflecting efforts to expand clinical and commercial deployment of its imaging solutions.
Another key news theme is the growth of Nanox.AI and its imaging analytics portfolio. Press releases describe AI algorithms that analyze routine CT scans for early signs associated with chronic diseases and bone health solutions such as HealthVCF and HealthOST, which have been included in an Early Value Assessment by the UK National Institute for Health and Care Excellence. Updates also discuss acquisitions like VasoHealthcare IT, intended to support deployment of AI solutions across U.S. healthcare facilities.
Investors and analysts can also find financial results announcements, guidance updates, and details of registered direct offerings and other financings, as reported in Nanox’s press releases and related SEC filings. Together, these news items provide insight into Nanox’s commercialization progress, clinical collaborations, AI development roadmap, and capital strategy. Bookmark this page to access an organized stream of Nanox news, from product and partnership updates to financial and regulatory disclosures.
NANO-X IMAGING LTD (NNOX) is set to report its third-quarter results for the period ending September 30, 2021, on November 17, 2021, before market opening. Ran Poliakine, the CEO, along with Erez Meltzer, the newly appointed CEO effective January 1, 2022, will lead a conference call at 8:30 a.m. ET to discuss the results and provide a business update. Interested parties can join via phone or webcast. Nanox aims to transform medical imaging with its innovative digital X-ray technology.
NANO-X IMAGING LTD (NNOX) has partnered with International Clinics Group to enhance medical imaging accessibility in Chile, Bolivia, and Peru. This collaboration aims to deploy the Nanox System, which includes the Nanox.ARC imaging device and Nanox.CLOUD services, across various healthcare facilities, subject to regulatory approval. The initiative addresses the shortage of medical imaging in rural areas, where access is limited. The World Health Organization indicates that two-thirds of the global population lacks adequate imaging services, emphasizing the need for such advancements.
NANO-X IMAGING (NNOX) announced the 8th FDA clearance for its Coronary Artery Calcium solution, enhancing its population health offerings via Zebra Medical Vision. This follows a merger agreement with Zebra aimed at expanding AI-based diagnostic capabilities for chronic conditions. Nanox aims to revolutionize medical imaging with its digital X-ray technology, potentially lowering costs and improving access to early detection services. The company highlights risks linked to acquisitions and regulatory clearances in its forward-looking statements.
Zebra Medical Vision has announced its eighth FDA 510(k) clearance for the HealthCCSng solution, designed to quantify coronary artery calcium (CAC) in existing non-gated CT scans to identify patients at risk for cardiovascular disease. This innovation aims to facilitate early diagnosis and treatment, thereby reducing healthcare costs. Zebra-Med's collaboration with Nanox is expected to enhance its AI capabilities and reach, supporting population health management and preventative care. The company emphasizes its commitment to improving healthcare outcomes through advanced imaging technologies.
Nano-X Imaging Ltd (Nasdaq: NNOX) announces an AI Vision event on October 27, 2021, at 8:30am ET. Hosted by Chairman and CEO Ran Poliakine and Director Erez Meltzer, the event will showcase the integration of AI technologies with Nano-X's imaging solutions, Nanox.ARC and Nanox.SOURCE. This initiative aims to enhance medical imaging systems' affordability and accessibility. The company seeks collaborations with healthcare organizations to provide early detection services. For more details, visit www.nanox.vision.
Nanox, a pioneering medical imaging technology company, announced that its CEO, Ran Poliakine, and Executive Chairman, Erez Meltzer, will present at the Cantor Fitzgerald Global Healthcare Conference on September 29, 2021, at 9:20 AM ET. A live webcast will be available through the company's website, with a replay accessible afterward. Nanox is focused on revolutionizing medical imaging by developing an affordable digital X-ray source aimed at collaboration with leading healthcare organizations to improve early detection imaging services.
Nanox to Host Business Update Webcast
On August 12, 2021, Nanox, a medical imaging technology company traded under NASDAQ: NNOX, announced a Business Update Video Presentation scheduled for August 16, 2021, at 8:30 am ET. CEO Ran Poliakine and senior leadership will discuss company advancements. Interested participants can register through the provided link. Nanox aims to reduce medical imaging costs with its innovative digital X-ray technology and seeks collaborations for affordable imaging services.
Nanox has announced a merger agreement with Zebra Medical Vision for $100 million upfront and $100 million in milestone payments. Additionally, it has entered a binding letter of intent to acquire USARAD Holdings Inc. for $30 million, comprising $21 million in shares and $9 million cash. These acquisitions aim to create a globally connected radiology solution and enhance population health management. Notably, Zebra Medical brings advanced AI technology and established relationships with healthcare providers worldwide.
NANO-X IMAGING LTD (NASDAQ: NNOX) announced a merger agreement to acquire Zebra Medical Vision for $100 million upfront and additional milestone payments. The company also signed a letter of intent to acquire USARAD for $30 million. These acquisitions aim to enhance their global radiology services and population health management. As of June 30, 2021, NANO-X reported a net loss of $13.6 million, with cash reserves of $193.4 million. Management transitions include Erez Meltzer becoming CEO in January 2022, with Ran Poliakine continuing as Executive Chairman.
NANO-X IMAGING LTD (NASDAQ: NNOX) will announce its Q2 2021 financial results on August 10, 2021, prior to market open. A conference call and webcast will be held at 8:30 AM ET on the same day. The company aims to revolutionize medical imaging with its commercial-grade digital X-ray technology, designed to lower costs and improve accessibility. Nanox plans to partner with leading healthcare organizations to enhance early detection services. Further details can be found on their website.